Candida auris, an emerging yeast species and potential infection source, is garnering significant attention in the medical realm due to its multi-drug resistance and tendency for colonization and transmission. This opens up the potential for outbreaks within medical institutions. This analysis shines a light on the first recorded case of C. auris in a pediatric bone marrow transplant patient within Guangxi, China. The yeast was isolated from the patient’s urine and recognized via matrix-assisted laser desorption ionization–time of flight (MALDI-TOF) mass spectrometry. The yeast was found to belong to clade I as determined by sequencing techniques.
To effectively mitigate the colonization of patients and control the spread within hospitals, infection control measures were increased, and regular surveillance screening of patients’ body surfaces and related medical equipment was performed. These measures, while aiming to control the spread of C. auris, also ensure the quality of patient diagnosis and treatment.
The initial case, explored in this paper, emerged from a hospital in Guangxi and involved a 14-year-old pediatric bone marrow transplant patient with a history of acute myeloid leukemia M2 who was subjected to comprehensive anti-infective treatment following hematopoietic stem cell transplantation. It was this patient’s urine that yielded the culture of C. auris.
Considering the substantial risk of patient morbidity and mortality associated with the colonization or infection of C. auris, particularly among hospitalized patients with serious illnesses, the implementation and maintenance of strict infection control measures are of paramount importance. This includes the isolation of patients in single rooms, the provision of dedicated medical equipment for individual use, and strict disinfection protocols, among others. The adherence to such protocols and regulations can substantially aid in the minimization of C. auris infections within medical institutions- thus ensuring patient health and safety.
Tags: Infection Prevention, Candida auris, Medical Institutions, Healthcare